Literature DB >> 23294522

Cost comparisons of various diagnostic medial branch block protocols and medial branch neurotomy in a private practice setting.

Richard Derby1, Irina Melnik, Jeong-Eun Lee, Sang-Heon Lee.   

Abstract

OBJECTIVE: We calculated the average total facility and professional cost of medial branch neurotomy (MBN) procedure and diagnostic medial branch blocks (MBBs), based on increments of MBB results (50-100% cutoff values), to determine the most cost-effective protocol that correlates with positive MBN outcome. DESIGN/
METHODS: We evaluated both actual cost and the theoretical cost of procedures in three groups: 0, single and double MBB. We calculated costs assuming MBB success rates at incrementally higher levels by incrementally raising the cutoff values for a successful diagnostic MBB by 10% increments (from 50% to 100%). We analyzed each cutoff value using the preposition that all patients meeting the cutoff value would proceed to MBN. Those not meeting the cutoff value would not have the cost of MBN added to the cost calculations. A cost per successful procedure was also analyzed.
RESULTS: Cost savings were noted when ≥70% cutoff MBB values were utilized and additionally when patients declined MBN for reasons other than their MBB outcome, although these dropouts lowered the cost-effectiveness of MBB when analyzed as cost per successful procedure. Costs over 5 years per successful procedure using 0, 1 and 2 diagnostic MBB protocol (x) and MBB protocol (o) were, however, similar at all MBB cutoff values.
CONCLUSIONS: Diagnostic MBB using progressively stringent MBB cutoff values incrementally excluded patients without posterior element pain as evidenced by incremental increase in positive outcomes following MBN. The exclusion of patients from MBN due to failure to report 70% or greater pain relief following MBB resulted in cost savings in favor of performing diagnostic MBB. Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23294522     DOI: 10.1111/pme.12026

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  6 in total

Review 1.  Is a One Prognostic Block Sufficient to Proceed with Radiofrequency Ablation? A Single Center Experience.

Authors:  Alaa Abd-Elsayed; Emily Narel; Michael Loebertman
Journal:  Curr Pain Headache Rep       Date:  2020-04-22

2.  Randomized prospective trial of cooled versus traditional radiofrequency ablation of the medial branch nerves for the treatment of lumbar facet joint pain.

Authors:  Zachary L McCormick; Heejung Choi; Rajiv Reddy; Raafay H Syed; Meghan Bhave; Mark C Kendall; Dost Khan; Geeta Nagpal; Masaru Teramoto; David R Walega
Journal:  Reg Anesth Pain Med       Date:  2019-03       Impact factor: 6.288

3.  Consensus practice guidelines on interventions for lumbar facet joint pain from a multispecialty, international working group.

Authors:  Steven P Cohen; Arun Bhaskar; Anuj Bhatia; Asokumar Buvanendran; Tim Deer; Shuchita Garg; W Michael Hooten; Robert W Hurley; David J Kennedy; Brian C McLean; Jee Youn Moon; Samer Narouze; Sanjog Pangarkar; David Anthony Provenzano; Richard Rauck; B Todd Sitzman; Matthew Smuck; Jan van Zundert; Kevin Vorenkamp; Mark S Wallace; Zirong Zhao
Journal:  Reg Anesth Pain Med       Date:  2020-04-03       Impact factor: 6.288

4.  Sensory mapping of lumbar facet joint pain: a feasibility study.

Authors:  Saravanakumar Kanakarajan; Kasun Fernando; Sudhindra Dharmavaram; Helen F Galley
Journal:  Br J Pain       Date:  2019-11-10

5.  Spinal Dorsal Rami Injection and Radiofrequency Neurolysis for Low Back Pain Caused by Osteoporosis-Induced Thoracolumbar Vertebral Compression Fractures.

Authors:  Linqiu Zhou; Jeffrey Zhou
Journal:  J Rehabil Med Clin Commun       Date:  2021-04-12

6.  Therapeutic lumbar facet joint nerve blocks in the treatment of chronic low back pain: cost utility analysis based on a randomized controlled trial.

Authors:  Laxmaiah Manchikanti; Vidyasagar Pampati; Alan D Kaye; Joshua A Hirsch
Journal:  Korean J Pain       Date:  2018-01-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.